To further investigate the possible role of these macrophages in the response of AML blasts to chemotherapy, specific depletion of CD169+ macrophages was conducted in mice followed by treatment with cytarabine and doxorubicin (60). The gene discussed is SIGLEC1; the disease is acute myeloid leukemia.